文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

持续炎症刺激下耐受性树突状细胞的生成

GENERATION OF TOLEROGENIC DENDRITIC CELLS UNDER THE PERSISTENT INFLAMMATION STIMULATION.
PubMed 文献 · Shock · 2024-02-27
一句话结论持续低剂量脂多糖刺激72小时可生成耐受性树突状细胞,其免疫抑制特征较IL-10诱导模型更贴近脓毒症免疫抑制阶段。

脓毒症后期常伴持续炎症与免疫抑制,但耐受性树突状细胞(tolDCs)的病理机制不清且缺乏合适细胞模型。本研究用亚致死剂量脂多糖(LPS)刺激72小时生成LPS-tolDCs并保持细胞活力,与经典的IL-10诱导tolDCs(IL-10-tolDCs)比较免疫耐受特征。两者均表现为成熟标志物表达降低、抑制性标志物水平升高,免疫调节活性相当,包括抗原提呈能力受损及抑制T细胞活化、增殖和分化。LPS-tolDCs在刺激后成熟和细胞因子产生反应更低,作者认为其可能更好地解释脓毒症继发感染易感性增加,并作为改善脓毒症免疫抑制状态的治疗靶点。

要点

  • 亚致死剂量LPS刺激72小时可生成耐受性树突状细胞(LPS-tolDCs),且保持细胞活力。
  • LPS-tolDCs与IL-10-tolDCs均显示成熟标志物表达降低、抑制性标志物水平升高。
  • LPS-tolDCs与IL-10-tolDCs免疫调节活性相当:抗原提呈能力受损,抑制T细胞活化、增殖和分化。
  • 与IL-10-tolDCs相比,LPS-tolDCs在刺激后成熟和细胞因子产生反应更低。
  • 作者认为LPS-tolDCs可能更好地解释脓毒症继发感染易感性增加,并作为改善免疫抑制状态的治疗靶点。

适用人群与场景

  • 脓毒症后期免疫抑制阶段的体外细胞模型研究,非直接患者人群。

研究设计与关键结果

  • 研究类型:体外细胞模型研究;方法:用亚致死剂量LPS刺激树突状细胞72小时生成LPS-tolDCs,并与IL-10诱导的tolDCs(IL-10-tolDCs)比较免疫耐受特征。
  • LPS-tolDCs与IL-10-tolDCs均表现为成熟标志物表达降低、抑制性标志物水平升高。
  • LPS-tolDCs与IL-10-tolDCs免疫调节活性相当,包括抗原提呈能力受损及抑制T细胞活化、增殖和分化。
  • 与IL-10-tolDCs相比,LPS-tolDCs在刺激后成熟和细胞因子产生反应更低。

证据类型、等级与局限

  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为LPS-tolDCs可能作为更好的研究模型,以阐明脓毒症继发感染易感性增加的机制。
  • 作者认为LPS-tolDCs是有前景的治疗靶点,用于改善脓毒症患者的免疫抑制状态。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Immunosuppression, commonly accompanied by persistent inflammation, is a key feature in the later phase of sepsis. However, the pathophysiological mechanisms underlying this phenomenon remain unclear. Dendritic cells (DCs), specifically tolerogenic DCs (tolDCs), play a crucial role in this process by regulating immune responses through inducing T cell anergy and releasing anti-inflammatory cytokines. Nevertheless, the existing cell models are inadequate for investigating tolDCs during the immunosuppressive phase of sepsis. Therefore, this study aimed to develop a novel in vitro model to generate tolDCs under chronic inflammatory conditions. We have successfully generated tolDCs by exposing them to sublethal lipopolysaccharide (LPS) for 72 h while preserving cell viability. Considering that IL-10-induced tolDCs (IL-10-tolDCs) are well-established models, we compared the immunological tolerance between LPS-tolDCs and IL-10-tolDCs. Our findings indicated that both LPS-tolDCs and IL-10-tolDCs exhibited reduced expression of maturation markers, whereas their levels of inhibitory markers were elevated. Furthermore, the immunoregulatory activities of LPS-tolDCs and IL-10-tolDCs were found to be comparable. These dysfunctions include impaired antigen presenting capacity and suppression of T cell activation, proliferation, and differentiation. Notably, compared with IL-10-tolDCs, LPS-tolDCs showed a reduced response in maturation and cytokine production upon stimulation, indicating their potential as a better model for research. Overall, in comparison with IL-10-tolDCs, our data suggest that the immunological dysfunctions shown in LPS-tolDCs could more effectively elucidate the increased susceptibility to secondary infections during sepsis. Consequently, LPS-tolDCs have emerged as promising therapeutic targets for ameliorating the immunosuppressed state in septic patients.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Miao S, Chang Z, Gu B, et al. GENERATION OF TOLEROGENIC DENDRITIC CELLS UNDER THE PERSISTENT INFLAMMATION STIMULATION. Shock. 2024. PMID: 38412105. doi:10.1097/SHK.0000000000002318

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。